These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11268384)

  • 21. Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms.
    Lissoni P
    Pathol Biol (Paris); 2007; 55(3-4):201-4. PubMed ID: 17446010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there a role for melatonin in supportive care?
    Lissoni P
    Support Care Cancer; 2002 Mar; 10(2):110-6. PubMed ID: 11862501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.
    Cerea G; Vaghi M; Ardizzoia A; Villa S; Bucovec R; Mengo S; Gardani G; Tancini G; Lissoni P
    Anticancer Res; 2003; 23(2C):1951-4. PubMed ID: 12820485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of cisplatin-induced anemia by the pineal indole 5-methoxytryptamine in metastatic lung cancer patients.
    Lissoni P; Malugani F; Bukovec R; Bordin V; Perego M; Mengo S; Ardizzoia A; Tancini G
    Neuro Endocrinol Lett; 2003; 24(1-2):83-5. PubMed ID: 12743539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha.
    Lissoni P; Vaghi M; Ardizzoia A; Malugani F; Fumagalli E; Bordin V; Fumagalli L; Bordoni A; Mengo S; Gardani GS; Tancini G
    In Vivo; 2002; 16(2):93-6. PubMed ID: 12073777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of cytokine production from TH2-lymphocytes and monocytes by the pineal neurohormone melatonin.
    Lissoni P; Pittalis S; Rovelli F; Roselli M; Ardizzoia A
    Oncol Rep; 1996 May; 3(3):541-3. PubMed ID: 21594408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pineal-opioid system interactions in the control of immunoinflammatory responses.
    Lissoni P; Barni S; Tancini G; Fossati V; Frigerio F
    Ann N Y Acad Sci; 1994 Nov; 741():191-6. PubMed ID: 7825805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract.
    Lissoni P; Barni S; Tancini G; Ardizzoia A; Rovelli F; Cazzaniga M; Brivio F; Piperno A; Aldeghi R; Fossati D
    Br J Cancer; 1993 Jun; 67(6):1404-7. PubMed ID: 8512825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of the mechanisms involved in the immunostimulatory action of the pineal hormone in cancer patients.
    Lissoni P; Barni S; Tancini G; Rovelli F; Ardizzoia A; Conti A; Maestroni GJ
    Oncology; 1993; 50(6):399-402. PubMed ID: 8233281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the pineal gland in the control of macrophage functions and its possible implication in cancer: a study of interactions between tumor necrosis factor-alpha and the pineal hormone melatonin.
    Lissoni P; Barni S; Tancini G; Brivio F; Tisi E; Zubelewicz B; Braczkowski R
    J Biol Regul Homeost Agents; 1994; 8(4):126-9. PubMed ID: 7660855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer immunotherapy with low-dose interleukin-2 subcutaneous administration: potential efficacy in most solid tumor histotypes by a concomitant treatment with the pineal hormone melatonin.
    Lissoni P; Barni S; Ardizzoia A; Olivini G; Brivio F; Tisi E; Tancini G; Characiejus D; Kothari L
    J Biol Regul Homeost Agents; 1993; 7(4):121-5. PubMed ID: 8023699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of cancer neuroimmunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin - a progress report of 200 patients with advanced solid neoplasms.
    Lissoni P; Ardizzoia A; Barni S; Brivio F; Tisi E; Rovelli F; Tancini G; Maestroni G; Fumagalli L
    Oncol Rep; 1995 Nov; 2(6):1063-8. PubMed ID: 21597854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue alone.
    Lissoni P; Cazzaniga M; Tancini G; Scardino E; Musci R; Barni S; Maffezzini M; Meroni T; Rocco F; Conti A; Maestroni G
    Eur Urol; 1997; 31(2):178-81. PubMed ID: 9076462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A biological study on the efficacy of low-dose subcutaneous interleukin-2 plus melatonin in the treatment of cancer-related thrombocytopenia.
    Lissoni P; Barni S; Brivio F; Rossini F; Fumagalli L; Ardizzoia A; Tancini G
    Oncology; 1995; 52(5):360-2. PubMed ID: 7637951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Principles of psychoneuroendocrinoimmunotherapy of cancer.
    Lissoni P; Rovelli F
    Immunotherapy; 2012 Jan; 4(1):77-86. PubMed ID: 22150002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to the light/dark rhythm of the pineal hormone melatonin in healthy humans.
    Lissoni P; Rovelli F; Brivio F; Brivio O; Fumagalli L
    Nat Immun; 1998; 16(1):1-5. PubMed ID: 9789119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia.
    Lissoni P; Bucovec R; Bonfanti A; Giani L; Mandelli A; Roselli MG; Rovelli F; Fumagalli L
    J Pineal Res; 2001 Mar; 30(2):123-6. PubMed ID: 11270479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin as a new possible anti-inflammatory agent.
    Lissoni P; Rovelli F; Meregalli S; Fumagalli L; Musco F; Brivio F; Brivio O; Esposti G
    J Biol Regul Homeost Agents; 1997; 11(4):157-9. PubMed ID: 9582617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pineal gland as a central regulator of cytokine network.
    Lissoni P
    Neuro Endocrinol Lett; 1999; 20(6):343-349. PubMed ID: 11458197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amplification of eosinophilia by melatonin during the immunotherapy of cancer with interleukin-2.
    Lissoni P; Ardizzoia A; Tisi E; Rossini F; Barni S; Tancini G; Conti A; Maestroni GJ
    J Biol Regul Homeost Agents; 1993; 7(1):34-6. PubMed ID: 8346714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.